MedTrace Logo

Injection of Hormone to Enhance Implantation in Embryo Transfer After IVF

NCT01986374 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2020-03-19

No results posted yet for this study

Summary

The endometrium is deprived of signals form the embryo in IVF conditions. Studies suggest that placing HCG into the uterus prior to embryo transfer can enhance implantation.

Conditions

Interventions

DRUG

HCG is introduced

must have good blastocysts

Sponsors & Collaborators

  • Servy Massey Fertility Insititute

    lead OTHER

Principal Investigators

  • Joe B Massey, MD · Servy Massey Fertilty Institute

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Max Age
47 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2015-12-31
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01986374 on ClinicalTrials.gov